Abstract
Perturbations to the immune system influence organismal aging, yet identifying effective therapeutic targets that mitigate aging-related tissue decline or the pathogenesis of aging-related diseases, such as cancer, remains challenging. In this Perspective, we focus on the dysfunction and loss of resident tissue macrophages (RTMs) with aging of certain tissues, which promote local inflammation, compromise tissue health and contribute to tumorigenesis. The abnormal genesis of RTMs from the bone marrow is a defining hallmark of both healthy and unhealthy aging. So, we propose that restoring RTMs—either by reshaping their niche and rescuing local self-renewal or by rejuvenating aging-associated myelopoiesis in the bone marrow—should be a major objective of interventions to promote healthy aging. We summarize the body of work supporting this conceptual framework and outline key future directions for the development of versatile myeloid-targeting therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Metchnikoff, É. The Nature of Man: Studies in Optimistic Philosophy (Heinemann, 1903).
Wong, C. K. et al. Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J. Immunol. 199, 1060–1068 (2017).
Yousefzadeh, M. J. et al. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell 19, e13094 (2020).
Moss, C. E. et al. Aging-related defects in macrophage function are driven by MYC and USF1 transcriptional programs. Cell Rep. 43, 114073 (2024).
Hou, J. et al. Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence. Nat. Aging 4, 1562–1581 (2024).
Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).
Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402–406 (2017).
Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018).
Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627–636 (2023).
Rodier, F. et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973–979 (2009).
Prieto, L. I. et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell 41, 1261–1275 (2023).
Haston, S. et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell 41, 1242–1260 (2023).
Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594, 100–105 (2021).
Walford, R. L. The immunologic theory of aging. Immunol. Rev. 2, 171 (1969).
Flores, K. G., Li, J., Sempowski, G. D., Haynes, B. F. & Hale, L. P. Analysis of the human thymic perivascular space during aging. J. Clin. Invest. 104, 1031–1039 (1999).
Sauce, D. et al. Evidence of premature immune aging in patients thymectomized during early childhood. J. Clin. Invest. 119, 3070–3078 (2009).
Akbar, A. N. & Henson, S. M. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat. Rev. Immunol. 11, 289–295 (2011).
Pang, W. W. et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl Acad. Sci. USA 108, 20012–20017 (2011).
Park, M. D., Silvin, A., Ginhoux, F. & Merad, M. Macrophages in health and disease. Cell 185, 4259–4279 (2022).
Machiels, B. et al. A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nat. Immunol. 18, 1310–1320 (2017).
Aegerter, H. et al. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection. Nat. Immunol. 21, 145–157 (2020).
Li, F. et al. Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection. Sci. Immunol. 7, eabj5761 (2022).
Bailey, J. I. et al. Profibrotic monocyte-derived alveolar macrophages are expanded in patients with persistent respiratory symptoms and radiographic abnormalities after COVID-19. Nat. Immunol. 25, 2097–2109 (2024).
Smallwood, H. S., López-Ferrer, D. & Squier, T. C. Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry 50, 9911–9922 (2011).
Jackaman, C. et al. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell 12, 345–357 (2013).
Bouchlaka, M. N. et al. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J. Exp. Med. 210, 2223–2237 (2013).
Thevaranjan, N. et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21, 455–466 (2017); erratum 23, 570 (2018).
Schloesser, D. et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47–QPCT/L axis. J. Cell Biol. 222, e202207097 (2023).
Wang, L. et al. Macrophage senescence in health and diseases. Acta Pharm. Sin. B 14, 1508–1524 (2024).
Subramaniam, R. et al. Delivery of GM-CSF to protect against influenza pneumonia. PLoS ONE 10, e0124593 (2015).
Wendeln, A.-C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332–338 (2018).
McQuattie-Pimentel, A. C. et al. The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging. J. Clin. Invest. 131, e140299 (2021).
Mogilenko, D. A. et al. Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging. Immunity 54, 99–115 (2021).
Park, M. D. et al. Hematopoietic aging promotes cancer by fueling IL-1α-driven emergency myelopoiesis. Science 386, eadn0327 (2024).
Adé, K. et al. Inflammation drives age-induced loss of tissue resident macrophages. Preprint at bioRxiv https://doi.org/10.1101/2022.10.02.510513 (2022).
Gonzalez-Hurtado, E. et al. Nerve-associated macrophages control adipose homeostasis across lifespan and restrain age-related inflammation. Preprint at bioRxiv https://doi.org/10.1101/2024.10.12.618004 (2024).
Mesa, K. R., O’Connor, K. A., Ng, C., Salvatore, S. P. & Littman, D. R. Niche-specific macrophage loss promotes skin capillary aging. Preprint at bioRxiv https://doi.org/10.1101/2023.08.25.554832 (2023).
Munro, D. A. D. et al. Microglia protect against age-associated brain pathologies. Neuron 112, 2732–2748 (2024).
Huang, F.-F. et al. GM-CSF in the lung protects against lethal influenza infection. Am. J. Respir. Crit. Care Med. 184, 259–268 (2011).
Chen, S. T. et al. A shift in lung macrophage composition is associated with COVID-19 severity and recovery. Sci. Transl. Med. 14, eabn5168 (2022).
Bosteels, C. et al. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment. Cell Rep. Med. 3, 100833 (2022).
Hartsock, R. J., Smith, E. B. & Petty, C. S. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. A study made from 177 cases of sudden death examined by necropsy. Am. J. Clin. Pathol. 43, 326–331 (1965).
Ricci, C. et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 177, 83–88 (1990).
Geiger, H., de Haan, G. & Florian, M. C. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13, 376–389 (2013).
Dykstra, B., Olthof, S., Schreuder, J., Ritsema, M. & de Haan, G. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J. Exp. Med. 208, 2691–2703 (2011).
Miller, J. P. & Allman, D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J. Immunol. 171, 2326–2330 (2003).
Young, K. et al. Progressive alterations in multipotent hematopoietic progenitors underlie lymphoid cell loss in aging. J. Exp. Med. 213, 2259–2267 (2016).
Jang, G. et al. Stem cell decoupling underlies impaired lymphoid development during aging. Proc. Natl Acad. Sci. USA 120, e2302019120 (2023).
Rossi, D. J. et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad. Sci. USA 102, 9194–9199 (2005).
Della Bella, S. et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 122, 220–228 (2007).
Wong, C. P., Magnusson, K. R. & Ho, E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp. Gerontol. 45, 163–169 (2010).
Xiao, J., Zhou, H., Wu, N. & Wu, L. The non-canonical Wnt pathway negatively regulates dendritic cell differentiation by inhibiting the expansion of Flt3+ lymphocyte-primed multipotent precursors. Cell. Mol. Immunol. 13, 593–604 (2016).
Chatterjee, V. & Gashev, A. A. Aging-associated shifts in functional status of mast cells located by adult and aged mesenteric lymphatic vessels. Am. J. Physiol. Heart Circ. Physiol. 303, H693–H702 (2012).
Chen, X. et al. Bone marrow myeloid cells regulate myeloid-biased hematopoietic stem cells via a histamine-dependent feedback loop. Cell Stem Cell 21, 747–760 (2017).
van Beek, A. A. et al. Aged mice display altered numbers and phenotype of basophils, and bone marrow-derived basophil activation, with a limited role for aging-associated microbiota. Immun. Ageing 15, 32 (2018).
Yvan-Charvet, L. & Ng, L. G. Granulopoiesis and neutrophil homeostasis: a metabolic, daily balancing act. Trends Immunol. 40, 598–612 (2019).
Barkaway, A. et al. Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage. Immunity 54, 1494–1510 (2021).
Sadeghi, H. M., Schnelle, J. F., Thomas, J. K., Nishanian, P. & Fahey, J. L. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp. Gerontol. 34, 959–970 (1999).
Zheng, Y. et al. A human circulating immune cell landscape in aging and COVID-19. Protein Cell 11, 740–770 (2020).
Cao, Y. et al. Phenotypic and functional alterations of monocyte subsets with aging. Immun. Ageing 19, 63 (2022).
Czimmerer, Z. et al. The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands. Immunity 55, 2006–2026 (2022).
Dang, B. et al. The glycolysis/HIF-1α axis defines the inflammatory role of IL-4-primed macrophages. Cell Rep. 42, 112471 (2023).
LaMarche, N. M. et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature 625, 166–174 (2024).
Grover, A. et al. Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells. Nat. Commun. 7, 11075 (2016).
Davizon-Castillo, P. et al. TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood 134, 727–740 (2019).
Poscablo, D. M. et al. An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis. Cell 187, 3090–3107 (2024).
Manso, B. A. et al. A rare HSC-derived megakaryocyte progenitor accumulates via enhanced survival and contributes to exacerbated thrombopoiesis upon aging. Preprint at bioRxiv https://doi.org/10.1101/2024.11.04.621964 (2024).
Aksöz, M. et al. Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved. Sci. Immunol. 9, eadk3469 (2024).
Satoh, Y. et al. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 38, 1105–1115 (2013).
Beerman, I. et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 12, 413–425 (2013).
Sun, D. et al. Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell 14, 673–688 (2014).
Adelman, E. R. et al. Aging human hematopoietic stem cells manifest profound epigenetic reprogramming of enhancers that may predispose to leukemia. Cancer Discov. 9, 1080–1101 (2019).
Kuribayashi, W. et al. Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche. J. Exp. Med. 218, e20192283 (2021).
Bogeska, R. et al. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell 29, 1273–1284 (2022).
Hong, T. et al. TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nat. Aging 3, 1387–1400 (2023).
Norddahl, G. L. et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 8, 499–510 (2011).
Kovtonyuk, L. V. et al. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood 139, 44–58 (2022).
Maryanovich, M. et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med. 24, 782–791 (2018).
Ho, Y.-H. et al. Remodeling of bone marrow hematopoietic stem cell niches promotes myeloid cell expansion during premature or physiological aging. Cell Stem Cell 25, 407–418 (2019).
Young, K. et al. Decline in IGF1 in the bone marrow microenvironment initiates hematopoietic stem cell aging. Cell Stem Cell 28, 1473–1482 (2021).
Mitchell, C. A. et al. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat. Cell Biol. 25, 30–41 (2023).
Kusumbe, A. P. et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature 532, 380–384 (2016).
Pioli, P. D., Casero, D., Montecino-Rodriguez, E., Morrison, S. L. & Dorshkind, K. Plasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow. Immunity 51, 351–366 (2019).
Thomas, S. et al. The Milieu Intérieur study—an integrative approach for study of human immunological variance. Clin. Immunol. 157, 277–293 (2015).
Dott, T. et al. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies. Cytometry A 105, 124–138 (2024).
Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843–1850 (2019).
Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253–268 (2012).
Schultze, J. L., Mass, E. & Schlitzer, A. Emerging principles in myelopoiesis at homeostasis and during infection and inflammation. Immunity 50, 288–301 (2019).
Hegde, S., Leader, A. M. & Merad, M. MDSC: markers, development, states, and unaddressed complexity. Immunity 54, 875–884 (2021).
Hegde, S. et al. Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors. Preprint at bioRxiv https://doi.org/10.1101/2024.06.24.600383 (2024).
Wu, C. et al. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. J. Clin. Invest. 128, 3425–3438 (2018).
Park, M. D. et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat. Immunol. 24, 792–801 (2023).
Jaillon, S. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer 20, 485–503 (2020).
Ng, M. S. F. et al. Deterministic reprogramming of neutrophils within tumors. Science 383, eadf6493 (2024).
He, X.-Y. et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell 42, 474–486 (2024).
Nash, G. F., Turner, L. F., Scully, M. F. & Kakkar, A. K. Platelets and cancer. Lancet Oncol. 3, 425–430 (2002).
Li, S. et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nat. Rev. Cancer 24, 72–87 (2024).
Abdel-Wahab, O. et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 22, 180–193 (2012).
Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374–382 (2017).
Yeaton, A. et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discov. 12, 2392–2413 (2022).
Kessler, M. D. et al. Common and rare variant associations with clonal haematopoiesis phenotypes. Nature 612, 301–309 (2022).
Caiado, F. et al. Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling. Blood 141, 886–903 (2023).
Ahmad, H., Jahn, N. & Jaiswal, S. Clonal hematopoiesis and its impact on human health. Annu. Rev. Med. 74, 249–260 (2023).
Jakobsen, N. A. et al. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Cell Stem Cell 31, 1127–1144 (2024).
Ross, J. B. et al. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature 628, 162–170 (2024).
Yamashita, M. & Passegué, E. TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell 25, 357–372 (2019).
Quin, C. et al. Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion. Blood Adv. 8, 4169–4180 (2024).
Caiado, F. & Manz, M. G. IL-1 in aging and pathologies of hematopoietic stem cells. Blood 144, 368–377 (2024).
Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285–299 (2013).
Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071–1079 (2023).
Zhang, S. et al. Platelet factor 4 (PF4) regulates hematopoietic stem cell aging. Preprint at bioRxiv https://doi.org/10.1101/2024.11.25.625252 (2024).
Grolleau-Julius, A., Harning, E. K., Abernathy, L. M. & Yung, R. L. Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res. 68, 6341–6349 (2008).
Zhivaki, D. et al. Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors. Cell 187, 3888–3903 (2024).
Chen, A. C. Y. et al. The aged tumor microenvironment limits T cell control of cancer. Nat. Immunol. 25, 1033–1045 (2024).
Phan, J. et al. Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis. Science 386, eado6836 (2024).
Pessoa Rodrigues, C. et al. Transcripts of repetitive DNA elements signal to block phagocytosis of hematopoietic stem cells. Science 385, eadn1629 (2024).
Chini, C. C. S. et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat. Metab. 2, 1284–1304 (2020).
Covarrubias, A. J. et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nat. Metab. 2, 1265–1283 (2020).
Sun, X. et al. Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells. Nat. Commun. 12, 2665 (2021).
Zeng, X. et al. A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cells. Nat. Aging 4, 1477–1492 (2024).
Song, Z. et al. An NAD+-dependent metabolic checkpoint regulates hematopoietic stem cell activation and aging. Nat. Aging 4, 1384–1393 (2024).
Dellorusso, P. V. et al. Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells. Cell Stem Cell 31, 1020–1037 (2024).
Chen, C., Liu, Y., Liu, Y. & Zheng, P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2, ra75 (2009).
Luo, Y. et al. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Transplantation 97, 20–29 (2014).
Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78–83 (2016).
He, Y. et al. Long-term clearance of senescent cells prevents the hematopoietic stem cell aging in naturally aged mice. Blood 134, 1204 (2019).
Hosseini, M. et al. Metformin treatment abrogates the competitive advantage of Dnmt3a R878H HSPCs by enhancing DNA methylation activity. Blood 140, 977–978 (2022).
Hosseini, M. et al. Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state. Preprint at ResearchSquare https://doi.org/10.21203/rs.3.rs-3874821/v1 (2024).
Shen, X. et al. Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J. Clin. Oncol. 36, 438–445 (2018).
Tao, Y. et al. Aging-like spontaneous epigenetic silencing facilitates Wnt activation, stemness, and BrafV600E-induced tumorigenesis. Cancer Cell 35, 315–328 (2019).
Bigenwald, C. et al. BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nat. Med. 27, 851–861 (2021).
Wilk, C. M. et al. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders. Immunity 56, 2790–2802 (2023).
Nagareddy, P. R. et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 19, 821–835 (2014).
Singer, K. et al. Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells. Mol. Metab. 3, 664–675 (2014).
Luche, E. et al. Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease. eLife 6, e23194 (2017).
Flynn, M. C. et al. Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circ. Res. 127, 877–892 (2020).
Andersson-Assarsson, J. C. et al. Evolution of age-related mutation-driven clonal haematopoiesis over 20 years is associated with metabolic dysfunction in obesity. EBioMedicine 92, 104621 (2023).
Pasupuleti, S. K. et al. Obesity-induced inflammation exacerbates clonal hematopoiesis. J. Clin. Invest. 133, e163968 (2023).
Jordan, S. et al. Dietary intake regulates the circulating inflammatory monocyte pool. Cell 178, 1102–1114 (2019).
Kim, Y. et al. Time-restricted feeding reduces monocyte production by controlling hematopoietic stem and progenitor cells in the bone marrow during obesity. Front. Immunol. 13, 1054875 (2022).
Janssen, H. et al. Monocytes re-enter the bone marrow during fasting and alter the host response to infection. Immunity 56, 783–796 (2023).
McAlpine, C. S. et al. Sleep exerts lasting effects on hematopoietic stem cell function and diversity. J. Exp. Med. 219, e20220081 (2022).
Rowley, M. J., Buchanan, H. & Mackay, I. R. Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet 2, 24–26 (1968).
Hijmans, W., Radil, J., Bottazzo, G. F. & Doniach, D. Autoantibodies in highly aged humans. Mech. Ageing Dev. 26, 83–89 (1984).
Ligthart, G. J. et al. Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech. Ageing Dev. 52, 235–243 (1990).
Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).
Fernbach, S. et al. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies. J. Exp. Med. 221, e20240365 (2024).
von Stemann, J. H. et al. Cytokine autoantibodies alter gene expression profiles of healthy donors. Eur. J. Immunol. 55, e202451211 (2025).
Author information
Authors and Affiliations
Contributions
Conceptualization: M.M. and M.D.P.; writing—original draft: M.D.P.; writing—reviewing and editing: M.M., D.J.P., D.C., N.Y. and J.Z.; assessment of literature: B.A.C., S.-K.Y. and M.M.S.
Corresponding author
Ethics declarations
Competing interests
M.M. serves on the scientific advisory board of and holds stock from Compugen Inc., Dynavax Inc., Asher Bio Inc., Dren Bio Inc., Genenta Inc., Oncoresponse Inc., Myeloid Therapeutics Inc., DemBio Inc. and Owkin Inc. M.M. serves on the scientific advisory board for contracted research from Genentech Inc., Regeneron Inc. and Boehringer Ingelheim Inc. M.M. is listed as an inventor on a patent application (#16/092576) submitted by the Icahn School of Medicine at Mount Sinai that covers the use of multiplex immunohistochemistry to characterize tumors and treatment responses. The technology is filed through the Icahn School of Medicine at Mount Sinai and is currently unlicensed. The other authors declare no competing interests.
Peer review
Peer review information
Nature Aging thanks Juan Pedro Martínez-Barbera, Irving Weissman and Yushi Yao for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Park, M.D., Yatim, N., Zhang, J. et al. Restoring resident tissue macrophages to combat aging and cancer. Nat Aging 5, 1383–1392 (2025). https://doi.org/10.1038/s43587-025-00898-y
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s43587-025-00898-y


